

Discover more from FarmaKology’s Substack
FarmaKology Newsletter - Issue #20
Today's Startup
Oncora Medical
Oncora Medical is a digital health company bringing real world data to radiation oncology. Founded in 2014, Oncora builds intuitive software tools to collect and use real world clinical data to improve outcomes for cancer patients. We are driven by our shared vision of a future where every cancer patient is offered a custom-tailored treatment plan based on their predicted treatment response.
News
Indian High Court rules against Bayer on Nexavar and Xarelto API exports
The Delhi High Court has allowed Alembic Pharmaceuticals and Natco Pharma to export sorafenib, an active ingredient in German pharma major Bayer’s cancer drug Nexavar, and rivaroxaban, the API in its blood thinner medicine Xarelto, for research and development purposes. The patent for Nexavar and Xarelto is scheduled to end next year.
Xynomic Research Institute successfully designs series of potent RET kinase inhibitors
Xynomic Pharmaceuticals Holdings, a clinical stage US-China oncology drug development company, announced that Xynomic Research Institute (XRI) has successfully designed a series of potent RET kinase inhibitors by computer-assisted drug design.
Scancell to begin SCIB1 UK trial as FDA issues linger in US
Immunotherapy developer Scancell announced the initiation of and further updates to the ‘SCIB1’ phase 2 trial in patients with metastatic melanoma also receiving the checkpoint inhibitor ‘pembrolizumab’ (Keytruda) on Monday.
2 rural Oregon pharmacies among top sellers of opioids in the U.S.
Two rural Oregon pharmacies sold more opioid pills per county resident than 99.9% of other pharmacies in the country, recently released federal data show.